Champions Oncology (2I3.STU) Q1 2026 Earnings

12MarConfirmed
Q1 2026
-0.02
0.01
0.05
0.08

Details

Expected EPS
0.0781335
Actual EPS
-0.017363
Surprise EPS
-0.1
Surprise Percent
+122.22%

Description

Champions Oncology (2I3.STU) has reported earnings of -0.017363 per share for Q1 2026.

0 Comments

Share your thoughts